TFF3 and chronic obstructive pulmonary disease: Under pathological conditions, TFF3 is increased in bronchoalveolar lavage (BAL) fluid from patients with chronic obstructive pulmonary disease (COPD) [16,17] as well as in the serum and sputum of COPD and asthma patients [18].